Bristol-Myers Squibb Company BMY | NYSE

$49.61 -$0.59 | -1.18%

After Hours
$49.91 $0.30 | 0.60%

Company Overview:

Market Cap: $100.96B
PE Ratio: 18.51
52-Week Range: $39.35 - $63.33
Dividend Yield (FWD): 5.00% ($2.48)

10 Year Performance Metrics:

Total Return (with DRIP): 6.18% (0.60% / yr)
Total Return (no DRIP): 5.65% (0.55% / yr)
Share Price: -24.05%
Dividend Increase: 67.57
BMY 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

BMY Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
BMY Dividend CAGR:1Y: 24.00%2Y: 4.29%5Y: 6.62%10Y: 5.30%
Share Price
BMY Price CAGR:1Y: 12.21%2Y: -14.84%5Y: -3.81%10Y: -2.61%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

BMY Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - BMY
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - BMY
14-Day FREE Trial Get Full Access Now!

BMY Earnings, Revenue, Cash & Debt, Shares Outstaning:

BMY - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
BMY - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
BMY - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
BMY - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
BMY - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
BMY - Cash & Debt
14-Day FREE Trial Get Full Access Now!
BMY - Revenue
14-Day FREE Trial Get Full Access Now!
BMY Revenue CAGR:1Y: 7.54%2Y: 4.02%5Y: 9.21%10Y: 11.23%
BMY - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
BMY EPS CAGR:1Y: -95.94%2Y: -80.72%5Y: 15.60%10Y: 16.30%
BMY - Net Income
14-Day FREE Trial Get Full Access Now!
BMY Net Income CAGR:1Y: -95.91%2Y: -81.13%5Y: 15.64%10Y: 18.67%
BMY - EBITDA
14-Day FREE Trial Get Full Access Now!
BMY EBITDA CAGR:1Y: -42.71%2Y: -26.44%5Y: 7.01%10Y: 42.87%
BMY - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
BMY Free Cash Flow CAGR:1Y: 3.54%2Y: 17.13%5Y: 17.84%10Y: 26.70%
BMY - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
BMY Free Cash Flow / Share CAGR:1Y: 3.44%2Y: 19.39%5Y: 16.48%10Y: 24.18%
BMY - Gross Profit
14-Day FREE Trial Get Full Access Now!
BMY Gross Profit CAGR:1Y: -13.77%2Y: -7.57%5Y: 6.67%10Y: 8.63%
BMY - Expenses
14-Day FREE Trial Get Full Access Now!
BMY Expenses CAGR:1Y: 14.55%2Y: 4.52%5Y: 8.53%10Y: 7.06%
BMY - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
BMY Shares Outstanding CAGR:1Y: 0.20%2Y: -2.07%5Y: 1.21%10Y: 1.99%
BMY - Share Buybacks
14-Day FREE Trial Get Full Access Now!
BMY Share Buybacks CAGR:1Y: 0.00%2Y: -100.00%5Y: -100.00%10Y: 0.00%
BMY - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
BMY Stock-Based Comp CAGR:1Y: -5.51%2Y: 0.42%5Y: -15.83%10Y: 6.16%
BMY - Dividends
14-Day FREE Trial Get Full Access Now!
BMY Dividend CAGR:1Y: 24.00%2Y: 4.29%5Y: 6.62%10Y: 5.30%
BMY - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
BMY Revenue CAGR:1Y: 7.54%2Y: 4.02%5Y: 9.21%10Y: 11.23%
BMY - Revenue by Region
14-Day FREE Trial Get Full Access Now!
BMY Revenue CAGR:1Y: 7.54%2Y: 4.02%5Y: 9.21%10Y: 11.23%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

BMY - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
BMY Actual Revenue CAGR:1Y: 7.54%2Y: 4.02%5Y: 9.21%10Y: 11.23%
BMY - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
BMY Actual EPS CAGR:1Y: -95.94%2Y: -80.72%5Y: 15.60%10Y: 16.30%
BMY - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
BMY Actual Net Income CAGR:1Y: -95.91%2Y: -81.13%5Y: 15.64%10Y: 18.67%
BMY - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
BMY Actual EBITDA CAGR:1Y: -42.71%2Y: -26.44%5Y: 7.01%10Y: 42.87%

Ratios, Profit Margins & Return on Capital:

BMY - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
BMY Net Profit Margin CAGR:1Y: -96.22%2Y: -81.91%5Y: 15.37%10Y: 6.46%
BMY - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
BMY Gross Profit Margin CAGR:1Y: -19.81%2Y: -11.14%5Y: -2.33%10Y: -2.34%
BMY - Price to Earnings
14-Day FREE Trial Get Full Access Now!
BMY - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
BMY - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
BMY - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

BMY Dividends Info:

Annual Dividend: $2.48
Forward Yield: 5%
Ex-Dividend Date: 2025-04-04
Lifetime Dividens / Share: $47.61

BMY Dividend History: Dates, Payments & Yield list

Below is a schedule of all BMY dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
04/04/202505/01/2025$0.6204.41%4.48%$55.30
01/03/202502/03/2025$0.6204.28%4.38%$56.57
10/04/202411/01/2024$0.6004.45%4.45%$53.96
07/05/202408/01/2024$0.6005.98%6.05%$39.66
05/06/202406/03/2024$0.5005.16%4.55%$43.99
04/04/202405/01/2024$0.6004.55%4.67%$51.40
01/04/202402/01/2024$0.6004.44%4.61%$52.04
10/05/202311/01/2023$0.5704.04%4.04%$56.42
07/06/202308/01/2023$0.5703.55%3.59%$63.44
04/06/202305/01/2023$0.5703.14%3.22%$70.74
01/05/202302/01/2023$0.5703.05%3.17%$71.92
10/06/202211/01/2022$0.5403.08%3.08%$70.24
06/30/202208/01/2022$0.5402.74%2.81%$77.00
03/31/202205/02/2022$0.5402.82%2.96%$73.03
01/06/202202/01/2022$0.5403.27%3.51%$61.48
09/30/202111/01/2021$0.4903.31%3.31%$59.17
07/01/202108/02/2021$0.4902.88%2.94%$66.56
03/31/202105/03/2021$0.4902.98%3.1%$63.13
12/31/202002/01/2021$0.4902.97%3.16%$62.03
10/01/202011/02/2020$0.4503.01%3.01%$59.82
07/02/202008/03/2020$0.4502.98%3.04%$59.14
04/02/202005/01/2020$0.4503.12%3.26%$55.21
01/02/202002/03/2020$0.4502.65%2.84%$63.34
10/03/201911/01/2019$0.4103.31%3.31%$49.55
07/03/201908/01/2019$0.4103.5%3.52%$46.56
04/04/201905/01/2019$0.4103.47%3.51%$46.67
01/03/201902/01/2019$0.4103.57%3.63%$45.12
10/04/201811/01/2018$0.4002.57%2.57%$62.36
07/05/201808/01/2018$0.4002.84%2.86%$55.95
04/05/201805/01/2018$0.4002.54%2.57%$62.31
01/04/201802/01/2018$0.4002.54%2.59%$61.75
10/05/201711/01/2017$0.3902.45%2.45%$63.80
07/05/201708/01/2017$0.3902.75%2.77%$56.35
04/05/201705/01/2017$0.3902.9%2.94%$53.08
01/04/201702/01/2017$0.3902.59%2.64%$59.14
10/05/201611/01/2016$0.3802.77%2.77%$54.79
06/29/201608/01/2016$0.3802.07%2.08%$73.00
03/30/201605/02/2016$0.3802.36%2.4%$63.44
12/30/201502/01/2016$0.3802.14%2.19%$69.52
09/30/201511/02/2015$0.3702.5%2.5%$59.20
07/01/201508/03/2015$0.3702.17%2.19%$67.67
04/01/201505/01/2015$0.3702.3%2.33%$63.56
12/30/201402/02/2015$0.3702.44%2.49%$59.39
10/01/201411/03/2014$0.3602.85%2.85%$50.53
07/01/201408/01/2014$0.3602.97%2.99%$48.12
04/02/201405/01/2014$0.3602.75%2.79%$51.59
12/31/201302/03/2014$0.3602.65%2.71%$53.15
10/02/201311/01/2013$0.3502.98%2.98%$46.93
07/02/201308/01/2013$0.3503.16%3.18%$43.99
04/03/201305/01/2013$0.3503.36%3.41%$41.07
01/02/201302/01/2013$0.3504.19%4.28%$32.71
10/03/201211/01/2012$0.3404.05%4.05%$33.56
07/03/201208/01/2012$0.3403.87%3.9%$34.91
04/03/201205/01/2012$0.3403.96%4.02%$33.87
01/04/201202/01/2012$0.3403.87%3.96%$34.34
10/06/201111/01/2011$0.3304.07%4.07%$32.45
06/29/201108/01/2011$0.3304.59%4.63%$28.54
03/30/201105/02/2011$0.3304.91%4.99%$26.47
01/05/201102/01/2011$0.3304.95%5.07%$26.06
09/29/201011/01/2010$0.3204.68%4.68%$27.37
06/30/201008/02/2010$0.3205.09%5.13%$24.94
03/30/201005/03/2010$0.3204.71%4.78%$26.76
12/30/200902/01/2010$0.3204.88%5%$25.61
09/30/200911/02/2009$0.3105.51%5.51%$22.52
07/01/200908/03/2009$0.3106.13%6.13%$20.24
04/01/200905/01/2009$0.3105.64%5.64%$21.97
12/30/200802/02/2009$0.3105.42%5.42%$22.87
10/01/200811/03/2008$0.3105.96%5.96%$20.79
07/02/200808/01/2008$0.3105.88%6.02%$20.59
04/02/200805/01/2008$0.3105.45%5.72%$21.66
01/02/200802/01/2008$0.3104.4%4.75%$26.13
10/03/200711/01/2007$0.2803.77%3.77%$29.74
07/03/200708/01/2007$0.2803.53%3.53%$31.77
04/03/200705/01/2007$0.2804.07%4.07%$27.54
01/03/200702/01/2007$0.2804.25%4.25%$26.38
10/04/200611/01/2006$0.2804.55%4.55%$24.62
07/05/200608/01/2006$0.2804.44%4.44%$25.22
04/05/200605/01/2006$0.2804.56%4.56%$24.54
01/04/200602/01/2006$0.2804.95%4.95%$22.63
10/05/200511/01/2005$0.2804.83%4.83%$23.17
06/29/200508/01/2005$0.2804.44%4.44%$25.21
03/30/200505/02/2005$0.2804.39%4.39%$25.54
01/05/200502/01/2005$0.2804.52%4.52%$24.79
09/29/200411/01/2004$0.2804.69%4.69%$23.86
06/30/200408/02/2004$0.2804.57%4.57%$24.50
03/31/200405/03/2004$0.2804.62%4.62%$24.23
12/30/200302/02/2004$0.2803.94%3.94%$28.42
10/01/200311/03/2003$0.2804.3%4.3%$26.03
07/01/200308/01/2003$0.2804.12%4.12%$27.18
04/02/200305/01/2003$0.2805.1%5.1%$21.97
12/31/200202/03/2003$0.2804.84%4.84%$23.15
10/02/200211/01/2002$0.2804.84%4.84%$23.13
07/02/200208/01/2002$0.2804.57%4.59%$24.40
04/03/200205/01/2002$0.2802.91%2.97%$37.70
01/02/200202/01/2002$0.2802.12%2.2%$50.85
10/03/200111/01/2001$0.2751.87%1.94%$56.75
07/03/200108/01/2001$0.2621.99%2.05%$51.06
04/04/200105/01/2001$0.2621.84%1.94%$53.87
01/03/200102/01/2001$0.2621.51%1.65%$63.59
10/04/200011/01/2000$0.2331.77%1.77%$52.82
07/05/200008/01/2000$0.2331.61%1.66%$56.10
04/05/200005/01/2000$0.2331.43%1.52%$61.33
01/05/200002/01/2000$0.2331.51%1.66%$56.10
09/29/199911/01/1999$0.2051.31%1.31%$62.34
06/30/199908/02/1999$0.2061.19%1.23%$67.04
03/30/199905/03/1999$0.2051.27%1.33%$61.63
01/06/199902/01/1999$0.2051.22%1.31%$62.43
09/30/199811/02/1998$0.1861.5%1.5%$49.43
06/30/199808/03/1998$0.1861.35%1.36%$54.70
04/01/199805/01/1998$0.1861.45%1.47%$50.50
12/30/199702/02/1998$0.1861.61%1.64%$45.30
10/01/199711/03/1997$0.1811.84%1.84%$39.29
07/01/199708/01/1997$0.1811.87%1.87%$38.64
04/02/199705/01/1997$0.1812.49%2.51%$28.85
12/31/199602/07/1997$0.1812.76%2.79%$25.94
10/02/199611/01/1996$0.1783.08%3.08%$23.20
07/02/199608/01/1996$0.1783.34%3.35%$21.30
04/02/199605/01/1996$0.1783.45%3.47%$20.55
01/03/199602/01/1996$0.1783.54%3.58%$19.96
10/04/199511/01/1995$0.1763.89%3.89%$18.11
07/05/199508/01/1995$0.1764.38%4.39%$16.03
04/03/199505/01/1995$0.1764.72%4.76%$14.81
12/30/199402/01/1995$0.1765.06%5.11%$13.77
10/03/199411/01/1994$0.1745.14%5.14%$13.53
06/27/199408/01/1994$0.1745.41%5.43%$12.79
03/25/199405/02/1994$0.1745.59%5.63%$12.34
01/03/199402/01/1994$0.1745.03%5.08%$13.68
09/27/199311/01/1993$0.1715.03%5.03%$13.62
06/28/199308/02/1993$0.1714.88%4.93%$13.89
03/29/199305/03/1993$0.1714.84%4.94%$13.86
01/04/199302/01/1993$0.1714.2%4.34%$15.79
09/28/199211/02/1992$0.1644.41%4.41%$14.90
06/26/199208/03/1992$0.1644.1%4.24%$15.50
03/30/199205/01/1992$0.1643.3%3.53%$18.62
12/27/199102/03/1992$0.1642.93%3.25%$20.20
09/30/199111/01/1991$0.1432.9%2.9%$19.69
06/28/199108/01/1991$0.1433%3.09%$18.50
04/01/199104/03/1991$0.1432.94%3.12%$18.29
12/28/199002/01/1991$0.1433.28%3.6%$15.88
10/01/199011/01/1990$0.1263.49%3.49%$14.46
06/29/199008/01/1990$0.1263.3%3.35%$15.08
04/02/199005/01/1990$0.1263.87%3.98%$12.67
12/29/198902/01/1990$0.1263.63%3.79%$13.32
09/19/198911/01/1989$0.1194.06%4.06%$11.72
06/30/198908/01/1989$0.1194.01%4.18%$11.39
04/03/198905/01/1989$0.1193.92%4.26%$11.18
12/30/198802/01/1989$0.1193.89%4.42%$10.77
10/03/198811/01/1988$0.1003.82%3.82%$10.47
06/27/198808/01/1988$0.1004.05%4.23%$9.46
03/25/198805/02/1988$0.1003.66%3.99%$10.02
01/04/198802/01/1988$0.1003.4%3.88%$10.29
09/28/198711/02/1987$0.0832.73%2.73%$12.19
06/26/198708/03/1987$0.0832.58%2.73%$12.22
03/30/198705/01/1987$0.0832.49%2.79%$11.93
12/26/198602/02/1987$0.0832.67%3.29%$10.11
09/29/198610/01/1986$0.0652.82%3.04%$8.61
06/27/198607/02/1986$0.0652.23%2.51%$10.44
12/27/198501/01/1986$0.0562.86%2.86%$7.82
09/30/198510/02/1985$0.0563.35%3.48%$6.42
06/28/198507/03/1985$0.0562.84%3.06%$7.30
03/29/198504/03/1985$0.0562.9%3.27%$6.84
12/28/198401/02/1985$0.0483.06%3.06%$6.22
10/01/198410/03/1984$0.0483.34%3.56%$5.34
06/29/198407/04/1984$0.0482.99%3.41%$5.58
04/02/198404/04/1984$0.0482.83%3.49%$5.46
12/30/198301/04/1984$0.0360%0%$0.00
10/03/198310/05/1983$0.0360%0%$0.00
07/01/198307/06/1983$0.0360%0%$0.00
04/04/198304/06/1983$0.0360%0%$0.00
01/03/198301/05/1983$0.0310%0%$0.00
10/04/198210/06/1982$0.0310%0%$0.00
07/02/198207/07/1982$0.0310%0%$0.00
04/02/198204/07/1982$0.0310%0%$0.00
01/04/198201/06/1982$0.0270%0%$0.00
10/05/198110/07/1981$0.0270%0%$0.00
07/06/198107/08/1981$0.0270%0%$0.00
05/01/198105/06/1981$0.0240%0%$0.00
04/06/198104/08/1981$0.0270%0%$0.00
10/06/198010/08/1980$0.0240%0%$0.00
06/30/198007/02/1980$0.0240%0%$0.00
03/28/198004/02/1980$0.0240%0%$0.00
12/28/197901/02/1980$0.0210%0%$0.00
10/05/197910/10/1979$0.0210%0%$0.00
06/29/197907/04/1979$0.0210%0%$0.00
04/02/197904/04/1979$0.0210%0%$0.00
12/29/197801/03/1979$0.0180%0%$0.00
10/02/197810/04/1978$0.0180%0%$0.00
06/30/197807/05/1978$0.0180%0%$0.00
03/31/197804/05/1978$0.0180%0%$0.00
12/30/197701/04/1978$0.0160%0%$0.00
10/03/197710/05/1977$0.0160%0%$0.00
06/27/197706/29/1977$0.0160%0%$0.00
03/30/197704/01/1977$0.0160%0%$0.00
12/29/197612/31/1976$0.0130%0%$0.00
09/28/197609/30/1976$0.0130%0%$0.00
06/28/197606/30/1976$0.0130%0%$0.00
03/29/197603/31/1976$0.0130%0%$0.00
12/26/197512/31/1975$0.0130%0%$0.00
09/29/197510/01/1975$0.0120%0%$0.00
06/27/197507/02/1975$0.0120%0%$0.00
03/31/197504/02/1975$0.0120%0%$0.00
12/27/197401/01/1975$0.0110%0%$0.00
09/30/197410/02/1974$0.0110%0%$0.00
06/28/197407/03/1974$0.0110%0%$0.00
03/28/197404/01/1974$0.0110%0%$0.00
12/28/197301/02/1974$0.0100%0%$0.00
10/01/197310/03/1973$0.0100%0%$0.00
07/30/197308/01/1973$0.0100%0%$0.00
04/30/197305/02/1973$0.0100%0%$0.00
01/29/197301/31/1973$0.0090%0%$0.00
10/31/197211/02/1972$0.0090%0%$0.00
07/26/197207/28/1972$0.0090%0%$0.00

Projected Future Returns & Dividends for BMY

Based on past 10-year performance, here are BMY growth metrics:

Share price CAGR of -2.61%
Dividend CAGR of +5.3%

Using BMY CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

BMY (DRIP)BMY - No DRIP
Current Price$49.61$49.61
Start Shares201.57201.57
Start Value$10,000$10,000
  
After 10 years:
Final Share Count414.79201.57
Dividends Payment$1.04$1.04
Annual Dividends$1,724$838
Yield on cost17.24%8.38%
Share Price$39.08$39.08
Total Dividends$9,118$6,376
Final Value$16,212$14,254

Estimated Future Value + Dividends - BMY

NOTE: Above numbers are our estimate based on BMY's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Bristol-Myers Squibb Company (BMY) had its IPO on 1972-06-01, and is trader on NYSE stock exchange.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

BMY website: https://www.bms.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial